This uncommissioned systematic review was subject to full peer-review.
Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis
Article first published online: 13 MAR 2013
© 2013 Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics
Volume 37, Issue 9, pages 845–854, May 2013
How to Cite
Parker, R., Armstrong, M. J., Corbett, C., Rowe, I. A. and Houlihan, D. D. (2013), Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis. Alimentary Pharmacology & Therapeutics, 37: 845–854. doi: 10.1111/apt.12279
- Issue published online: 3 APR 2013
- Article first published online: 13 MAR 2013
- Manuscript Accepted: 19 FEB 2013
- Manuscript Revised: 18 FEB 2013
- Manuscript Revised: 12 FEB 2013
- Manuscript Received: 22 JAN 2013
Figure S1. Pentoxifylline vs. placebo, 28-day mortality.
Figure S2. Pentoxifylline vs. placebo, incidence of fatal HRS.
Figure S3. Pentoxifylline vs. prednisolone, 28-day survival.
Figure S4. Pentoxifylline vs. combination therapy, 28-day survival.
Figure S5. Pentoxifylline vs. combination therapy, 6-month survival.
Figure S6. Pentoxifylline vs. combination therapy, incidence of HRS.
Table S1. Quality of trials published as full manuscripts assessed by CONSORT criteria.
Table S2. Quality of trials published as abstracts assessed by CONSORT guidelines.
Table S3. Outcomes: 28-day mortality, 6-month mortality and incidence of HRS (%) (analysed with Fisher's exact test).
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.